Home

MPM BIOVENTURES III-QP L.P.

CIK 1173409 · last filed 2012-06-04

MPM BIOVENTURES III-QP L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $1.7M of SOMX on Jun 4, 2012. Across all open-market trades the lifetime net is +$65.9M, making them a net buyer over the disclosed history. The firm reports its address in Boston, MA. 107 SEC filings were submitted jointly with MPM BIOVENTURES III GMBH & CO. Beteiligungs KG.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

6

Lifetime Open-Market Net

$65.86M

Filer Profile

Reported Address
C/O MPM ASSET MANAGEMENT
200 CLARENDON ST., 54TH FLOOR
BOSTON, MA 02116
Phone
(617) 425-9200
State of Incorporation
DE
Formerly Known As
MPM BIOVENTURES III QP LP (2004–2009)
MPM BIO VENTURES III QP LP (2002–2003)
Related Filers
MPM BIOVENTURES III GMBH & CO. Beteiligungs KG — 107 joint filings, latest 2016-09-29
MPM BIOVENTURES III GP L.P. — 107 joint filings, latest 2016-09-29
MPM BIOVENTURES III L.P. — 107 joint filings, latest 2016-09-29
MPM BIOVENTURES III LLC — 107 joint filings, latest 2016-09-29
MPM BIOVENTURES III PARALLEL FUND, L.P. — 93 joint filings, latest 2016-09-29
MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC — 51 joint filings, latest 2016-09-29
MICHAEL STEINMETZ — 40 joint filings, latest 2016-09-29
KURT WHEELER — 34 joint filings, latest 2007-01-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Pernix Sleep, Inc. (SOMX) Delisted 10%+ Owner 481,374 — — -$1.71M 1 2012-06-04
ARYx Therapeutics, Inc. (ARYX) Delisted 10%+ Owner — — — $0 1 2010-10-04
ReShape Weightloss Inc. (ETRM) Delisted 10%+ Owner 965,140 — — $14.21M 1 2009-02-25
Altimmune, Inc. (PIP) Delisted 10%+ Owner 336,444 — — $6.74M 1 2007-10-03
Altimmune, Inc. (HAQ.WS) Delisted 10%+ Owner 3,343,250 — — $6.74M 1 2007-08-07
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted 10%+ Owner 6,858,211 — — $39.88M 1 2007-05-01

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-06-04 Pernix Sleep, Inc. (SOMX) Delisted Sell (S) −5,679,954 -$1.71M EDGAR
2010-10-04 ARYx Therapeutics, Inc. (ARYX) Delisted Buy (P) — $0 EDGAR
2009-02-25 ReShape Weightloss Inc. (ETRM) Delisted Buy (P) +12,358,493 $14.21M EDGAR
2007-10-03 Altimmune, Inc. (PIP) Delisted Mixed +23,551,101 $6.74M EDGAR
2007-08-07 Altimmune, Inc. (HAQ.WS) Delisted Mixed +23,402,750 $6.74M EDGAR
2007-05-01 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Buy (P) +6,300,000 $39.88M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.